Stein L, Wise C D, Belluzzi J D
Adv Biochem Psychopharmacol. 1975(14):29-44.
If the rat conflict test were a valid animal model of anxiety neurosis, evidence which implicates serotonin systems in the anxiety-reducing actions of benzodiazepine tranquilizers could be summarized as follows: (1) The punishment-lessening effects of benzodiazepines in the conflict test are mimicked by serotonin antagonists (methysergide, cinanserin, bromolysergic acid), serotonin synthesis inhibition (PCPA), and serotonin nerve terminal damage (5,6-dihydroxytryptamine). (2) Punishment effects may be intensified by the serotonin precursor, 5-hydroxytryptophan (in combination with a monoamine oxidase inhibitor), serotonin agonists (alpha-methyltryptamine), or intraventricular injections of serotonin itself. Intraventricularly administered serotonin also antagonizes the punishment-lessening effects of benzodiazepines. (3) Stimulation of the serotonergic cell bodies in the dorsal raphe nucleus by local application of crystalline carbachol causes intense suppression of behavior. The suppressive effects of raphe stimulation are antagonized by systemic administration of benzodiazepines. (4) In biochemical experiments, the decrease in norepinephrine turnover induced by oxazepam rapidly undergoes tolerance, whereas the decrease induced in serotonin turnover is maintained over repeated doses. These results parallel findings in the conflict test which indicate that the depressant action of oxazepam rapidly undergoes tolerance, whereas the anxiety-reducing action is maintained over repeated doses. Although central serotonin neurons are thus implicated in the therapeutic actions of benzodiazepine tranquilizers, it is quite possible that the drugs actually act indirectly to reduce serotonin activity. The concept that benzodiazepines may exert a primary action on GABA-containing neurons, which in turn regulate serotonergic transmission, was supported by preliminary psychopharmacological evidence. The GABA-antagonist picrotoxin, at doses that do not disrupt unpunished behavior, fully antagonizes the punishment-lessening effects of benzodiazepines in the conflict test.
如果大鼠冲突试验是焦虑神经症的有效动物模型,那么涉及血清素系统在苯二氮䓬类镇静剂抗焦虑作用中的证据可总结如下:(1) 血清素拮抗剂(甲基麦角新碱、肉桂硫胺、溴麦角隐亭)、血清素合成抑制(对氯苯丙氨酸)和血清素神经末梢损伤(5,6 - 二羟基色胺)可模拟苯二氮䓬类药物在冲突试验中的减轻惩罚作用。(2) 血清素前体5 - 羟色氨酸(与单胺氧化酶抑制剂合用)、血清素激动剂(α - 甲基色胺)或脑室内注射血清素本身可增强惩罚作用。脑室内注射血清素也可拮抗苯二氮䓬类药物的减轻惩罚作用。(3) 局部应用结晶卡巴胆碱刺激中缝背核中的血清素能细胞体会导致行为强烈抑制。中缝刺激的抑制作用可被全身给予苯二氮䓬类药物拮抗。(4) 在生化实验中,奥沙西泮诱导的去甲肾上腺素周转率降低迅速产生耐受性,而血清素周转率的降低在重复给药后仍持续存在。这些结果与冲突试验中的发现一致,即奥沙西泮的抑制作用迅速产生耐受性,而抗焦虑作用在重复给药后仍持续存在。虽然中枢血清素神经元因此与苯二氮䓬类镇静剂的治疗作用有关,但药物实际上很可能是间接作用以降低血清素活性。苯二氮䓬类药物可能对含γ - 氨基丁酸(GABA)的神经元发挥主要作用,进而调节血清素能传递,这一概念得到了初步精神药理学证据的支持。γ - 氨基丁酸拮抗剂印防己毒素在不干扰无惩罚行为的剂量下,可完全拮抗苯二氮䓬类药物在冲突试验中的减轻惩罚作用。